Superstock Investor
Member Login   RSS ->
James DiGeorgia, Mr. Macro
- Chief Editor -
Mr. Macro
Geoff Garbacz, Mr. Micro
- Chief Strategist -
Mr. Micro
Dan Hassey, Mr. Retirement
- Senior Stock Analyst -
Mr. Retirement
Superstock Investor

[Printable Version of This Page]

Today's Superstock Investor Stock Scorecard:

Bristol-Myers Squibb Company (BMY)
by Superstock Investor

January 4, 2019


Bristol Myers (BMY) is buying Celgene (CELG) for $102.43. So how did our price target and upper bound do on this purchase for the acquirer? The stock is at $45.12.

Company Information

Company: Bristol-Myers Squibb Company
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Market Cap:  $98,696,500,000


  Price %Gain  
Current Price $53.28    
Price Target $53.28 0.0%  
Upper Bound $66.60 25.0%  
Lower Bound $45.29 -15.0%  

Stock data last updated 12/03/2018.

Data provided by QPI, Inc. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. QPI, Inc. is not liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing this page, you agree not to redistribute the information found herein.

Stock Scorecard Archives